Starcoin Group Ltd
00399
Company Profile
Business description
Starcoin Group Ltd, formerly Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong.
Contact
145 Hennessy Road
Unit No. 2002, 20th Floor, On Hong Commercial Building
Wan Chai
Hong Kong
HKGT: +852 25986818
Sector
Consumer Cyclical
Stock type
Cyclical
Industry
Specialty Retail
Fiscal Year End
31 March 2027
Employees
29
Stocks News & Analysis
stocks
Big 4 earnings: Morningstar analysts form view on impact of slowing housing market
Big 4 bank maintains Fair Value, Short-term earnings not material enough to shift valuation for key player
stocks
ASX healthcare share remains cheap despite mixed earnings result
Shares in Aussie listed healthcare name undervalued post earnings.
stocks
Wide moat ASX share beats earnings guidance
Wide moat share continues to grow despite a challenging residential construction market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,443.70 | 17.90 | 0.19% |
| CAC 40 | 8,714.94 | 11.09 | -0.13% |
| DAX 40 | 26,391.42 | 67.54 | 0.26% |
| Dow JONES (US) | 53,775.77 | 200.21 | -0.37% |
| FTSE 100 | 10,844.19 | 18.31 | -0.17% |
| HKSE | 25,652.82 | 284.67 | -1.10% |
| NASDAQ | 26,451.52 | 153.83 | -0.58% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,860.66 | 27.58 | -0.20% |
| S&P 500 | 7,726.89 | 26.22 | -0.34% |
| S&P/ASX 200 | 9,250.60 | 13.80 | 0.15% |
| SSE Composite Index | 3,934.09 | 32.50 | -0.82% |